| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
021-61312847; 18021002903 |
| Email: |
3008007409@qq.com |
| Products Intro: |
Product Name:Brazikumab (anti-IL-23)
CAS:1610353-18-8
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:5mg Remarks:K10769
|
| Company Name: |
ShangHai Biochempartner Co.,Ltd
|
| Tel: |
177-54423994 17754423994 |
| Email: |
2853530910@QQ.com |
| Products Intro: |
Product Name:Brazikumab
CAS:1610353-18-8
Purity:95% Package:100ug;500ug;1mg
|
| Company Name: |
Guangzhou Hongyuan Chemical Co.,Ltd
|
| Tel: |
15817493340 |
| Email: |
981810490@qq.com |
| Products Intro: |
Product Name:Brazikumab
CAS:1610353-18-8
Purity:95% Package:1mg;1g;100g
|
Brazikumab manufacturers
- Brazikumab
-
- $197.00 / 1mg
-
2026-03-02
- CAS:1610353-18-8
- Min. Order:
- Purity: 95.00%
- Supply Ability: 10g
|
| | Brazikumab Basic information |
| Product Name: | Brazikumab | | Synonyms: | Brazikumab;Research Grade Brazikumab(DHJ63104);Brazikumab (anti-IL-23);Research Grade Brazikumab | | CAS: | 1610353-18-8 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Brazikumab Structure]() |
| | Brazikumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Brazikumab Usage And Synthesis |
| Uses | Brazikumab (AMG 139) is a human IgG2 monoclonal antibody, selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for the research of Crohn's disease[1]. | | IC 50 | IL-23: 0.138 nM (Kd) | | References | [1] Currò D, et, al. Frontiers in Drug Research and Development for Inflammatory Bowel Disease. Front Pharmacol. 2017 Jun 23;8:400. DOI:10.3389/fphar.2017.00400
[2] Al-Bawardy B, et, al. Novel and Emerging Therapies for Inflammatory Bowel Disease. Front Pharmacol. 2021 Apr 14;12:651415. DOI:10.3389/fphar.2021.651415 |
| | Brazikumab Preparation Products And Raw materials |
|